Literature DB >> 2431172

[Surgical treatment of far-advanced gastric cancer].

K Okajima, S Yamada.   

Abstract

Surgical treatment of far-advanced gastric cancer should be categorized as part of a multidisciplinary treatment. Its therapeutic principles may be summarized as follows: survival should be expected; operative death must be avoided; any operation promoting the growth of cancer should be avoided; oral intake should be made possible, pain should be eased; and the main focus must be removed as far as possible. In the cases with positive peritoneal dissemination, even at P3, a significant extension of life is recognized in the palliative gastrectomy group as compared with the non-resected group. However, considering the postoperative length of life, palliative gastrectomy seems applicable to cases of P1, H1, partly to H2, n3(+), and S3, but in more advanced cases, it was learned essential to determine the surgical method in consideration of the nature of the cancer in the individual cases.

Entities:  

Mesh:

Year:  1986        PMID: 2431172

Source DB:  PubMed          Journal:  Gan No Rinsho        ISSN: 0021-4949


  5 in total

1.  Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.

Authors:  Lie-Jun Mei; Xiao-Jun Yang; Li Tang; Alaa Hammed Al-Shammaa Hassan; Yutaka Yonemura; Yan Li
Journal:  BMC Cancer       Date:  2010-04-01       Impact factor: 4.430

2.  Gross Appearance and Curability Are Predictive Factors of a Better Prognosis After Gastrectomy in Gastric Cancer Patients with Metastasis to the Adjacent Peritoneum of the Stomach.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Osaki Tomohiro; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2017-09-15       Impact factor: 1.641

3.  Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.

Authors:  Kyo Young Song; Joyce Wong; Lorena Gonzalez; Gang Sheng; Dmitriy Zamarin; Yuman Fong
Journal:  J Mol Med (Berl)       Date:  2010-06       Impact factor: 4.599

4.  Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.

Authors:  Masayoshi Hioki; Naoto Gotohda; Masaru Konishi; Toshio Nakagohri; Shinichiro Takahashi; Taira Kinoshita
Journal:  World J Surg       Date:  2010-03       Impact factor: 3.352

5.  Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.

Authors:  Maneesh Kumarsing Beeharry; Zheng-Lun Zhu; Wen-Tao Liu; Xue-Xin Yao; Min Yan; Zheng-Gang Zhu
Journal:  BMC Cancer       Date:  2019-09-18       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.